PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 8,784,385 | Frozen piercing implements and methods for piercing a substrate | Sep 15, 09 | Jul 22, 14 | THE INVENTION SCIENCE FUND I, LLC |
| 8,784,777 | Flexibly labeling peptides | Nov 29, 10 | Jul 22, 14 | CASE WESTERN RESERVE UNIVERSITY |
| 8,784,809 | Vascular endothelial growth factor 2 | Jan 24, 13 | Jul 22, 14 | HUMAN GENOME SCIENCES, INC. |
| 8,784,811 | Method of treating cancer using antibodies to a non-ligand binding region of NOTCH1 | Feb 22, 13 | Jul 22, 14 | ONCOMED PHARMACEUTICALS, INC. |
| 8,784,814 | Method for inhibiting binding to B-cell receptor | Jun 28, 12 | Jul 22, 14 | GLAXO GROUP LIMITED |
| 8,784,823 | Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof | Oct 22, 12 | Jul 22, 14 | BIOGEN IDEC MA INC.; UCB BIOPHARMA SPRL; |
| 8,784,825 | Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC | Aug 28, 09 | Jul 22, 14 | TAIGA BIOTECHNOLOGIES, INC. |
| 8,784,828 | proteins, nucleic acids, and methods of their use | May 05, 08 | Jul 22, 14 | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION |
| 8,784,829 | vaccines | Oct 21, 09 | Jul 22, 14 | INTERVET INC. |
| 8,784,830 | Antigen peptide and use thereof | May 23, 11 | Jul 22, 14 | Not available |
| 8,784,833 | Prenatal enzyme replacement therapy for hypophosphatasia | Jan 17, 11 | Jul 22, 14 | SAINT LOUIS UNIVERSITY |
| 8,785,135 | Mutant G-protein coupled receptors and methods for selecting them | Mar 20, 08 | Jul 22, 14 | HEPTARES THERAPEUTICS LIMITED |
| 8,785,151 | Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues | Oct 23, 09 | Jul 22, 14 | Not available |
| 8,785,369 | Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration | Jan 26, 09 | Jul 22, 14 | MOREHOUSE SCHOOL OF MEDICINE |
| 8,785,376 | Isolation, identification, and uses of antifungal compounds | Dec 20, 11 | Jul 22, 14 | VIRGINIA TECH INTELLECTUAL PROPERTIES; UNIVERSITY OF UTAH RESEARCH FOUNDATION; |
| 8,785,377 | Tetrazolyl macrocyclic hepatitis C serine protease inhibitors | Jan 18, 08 | Jul 22, 14 | ENANTA PHARMACEUTICALS, INC. |
| 8,785,385 | RTEF-1 variants and uses thereof | Apr 19, 11 | Jul 22, 14 | RESEARCH DEVELOPMENT FOUNDATION; OREGON HEALTH & SCIENCE UNIVERSITY; |
| 8,785,388 | TAT-BH3 methods for treating arthritis | Feb 14, 08 | Jul 22, 14 | SAINT LOUIS UNIVERSITY |
| 8,785,391 | Compound and method for treatment of alzheimer's disease and familial dementia | Jun 24, 10 | Jul 22, 14 | ALPHABETA AB |
| 8,785,392 | Method for inhibiting cancer metastasis by administration of the extracellular domain DLK1 or a DLK1-FC fusion protein | Apr 13, 10 | Jul 22, 14 | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2014/0205,560 | MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME | Jul 19, 13 | Jul 24, 14 | ALTOR BIOSCIENCE CORPORATION |
| 2014/0205,562 | IL-1 BINDING PROTEINS | Dec 18, 13 | Jul 24, 14 | ABBVIE INC. |
| 2014/0205,568 | Promyelocytic Leukemia Protein as a Redox Sensor | Mar 07, 14 | Jul 24, 14 | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
| 2014/0205,570 | RECOMBINANT ADENO-ASSOCIATED VIRUS-MEDIATED EXPRESSION OF FRACTALKINE FOR TREATMENT OF NEUROINFLAMMATORY AND NEURODEGENERATIVE DISEASES | Jun 30, 12 | Jul 24, 14 | THE UNIVERSITY OF SOUTH FLORIDA |
| 2014/0205,588 | PLASMINOGEN AND PLASMIN VARIANTS | Aug 13, 12 | Jul 24, 14 | THROMBOGENICS NV |
| 2014/0205,593 | MONOVALENT ANTIBODY FRAGMENTS USEFUL AS THERAPEUTICS | Apr 15, 13 | Jul 24, 14 | GENENTECH, INC. |
| 2014/0205,597 | TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | Dec 23, 13 | Jul 24, 14 | ABLYNX N.V. |
| 2014/0205,598 | Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation | Jan 30, 14 | Jul 24, 14 | UNIVERSITY OF LEICESTER; OMEROS CORPORATION; |
| 2014/0205,599 | POLYPEPTIDE THAT BINDS ABERRANT CELLS AND INDUCES APOPTOSIS | Dec 22, 11 | Jul 24, 14 | Not available |
| 2014/0205,600 | METHODS OF PROMOTING FAT LOSS COMPRISING ADMINISTERING AN ALK7 INHIBITOR | Jan 24, 14 | Jul 24, 14 | ACCELERON PHARMA INC. |
| 2014/0205,601 | AMINO ACID SEQUENCES DIRECTED AGAINST RANK-L AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF BONE DISEASES AND DISORDERS | Dec 11, 13 | Jul 24, 14 | ABLYNX N.V. |
| 2014/0205,602 | ANTAGONIST ANTI-CD40 MONOCLONAL ANTIBODIES AND METHODS FOR THEIR USE | Dec 19, 13 | Jul 24, 14 | NOVARTIS VACCINES AND DIAGNOSTICS INC. |
| 2014/0205,603 | SIGLEC-15 ANTIBODIES IN TREATING BONE LOSS-RELATED DISEASE | Jan 07, 14 | Jul 24, 14 | ALETHIA BIOTHERAPEUTICS INC. |
| 2014/0205,604 | ANTIGEN BINDING CONSTRUCTS | Jul 25, 12 | Jul 24, 14 | GLAXO GROUP LIMITED |
| 2014/0205,605 | OPTIMIZED ANTIBODIES THAT TARGET HM1.24 | Mar 11, 13 | Jul 24, 14 | XENCOR INC. |
| 2014/0205,606 | ANTI C-MET ANTIBODIES | Dec 06, 13 | Jul 24, 14 | ARGEN-X B.V. |
| 2014/0205,607 | FOCUSED EVOLUTION OF HIV-1 NEUTRALIZING ANTIBODIES REVEALED BY CRYSTAL STRUCTURES AND DEEP SEQUENCING | Mar 23, 12 | Jul 24, 14 | DUKE UNIVERSITY; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH; THE U.S.A. AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES; |
| 2014/0205,608 | Use of c-Fms antagonists | Jul 17, 12 | Jul 24, 14 | MORPHOSYS AG; THE UNIVERSITY OF MELBOURNE; |
| 2014/0205,610 | ANTI-FOLR1 ANTIBODY | Nov 25, 13 | Jul 24, 14 | KYOWA HAKKO KIRIN CO., LTD. |
| 2014/0205,611 | MONOCLONAL ANTIBODIES THAT BIND TO HGM-CSF AND MEDICAL COMPOSITIONS COMPRISING SAME | Jan 28, 14 | Jul 24, 14 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH; EVEC INC.; |
